ArticleCureus2025
Multimodal Artificial Intelligence Using Endoscopic USG, CT, and MRI to Differentiate Between Serous and Mucinous Cystic Neoplasms.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence in Pancreatic Endoscopic Ultrasonography: From Image-Based Diagnosis to Cytopathology.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Serous cystic neoplasms (SCN) and mucinous cystic neoplasms (MCN) often exhibit similar imaging features when evaluated with a single imaging modality. Differentiating between SCN and MCN typically necessitates the utilization of multiple imaging techniques, including computed tomography (CT), magnetic resonance imaging (MRI), and endoscopic ultrasonography (EUS). Recent research indicates that artificial intelligence (AI) can effectively distinguish between SCN and MCN using single-modal imaging. Despite these advancements, the diagnostic performance of AI has not yet reached an optimal level. This study compares the efficacy of AI in classifying SCN and MCN using multimodal imaging versus single-modal imaging. The objective was to assess the effectiveness of AI utilizing multimodal imaging with EUS, CT, and MRI to classify these two types of pancreatic cysts. Methods We retrospectively gathered data from 25 patients with surgically confirmed SCN and 24 patients with surgically confirmed MCN as part of a multicenter study. Imaging was conducted using four modalities: EUS, early-phase contrast-enhanced abdominal CT, T2-weighted MRI, and magnetic resonance pancreatography. Four images per modality were obtained for each tumor. Data augmentation techniques were utilized, resulting in a final dataset of 39,200 images per modality. An AI model with ResNet was employed to categorize the cysts as SCN or MCN, incorporating clinical features and combinations of imaging modalities (single, double, triple, and all four modalities). The classification outcomes were compared with those of five experienced gastroenterologists with over 10 years of experience. The comparison is based on three performance metrics: sensitivity, specificity, and accuracy. Results For AI utilizing a single imaging modality, the sensitivity, specificity, and accuracy were 87.0%, 92.7%, and 90.8%, respectively. Combining two imaging modalities improved the sensitivity, specificity, and accuracy to 95.3%, 95.1%, and 94.9%. With three modalities, AI achieved a sensitivity of 96.0%, a specificity of 99.0%, and an accuracy of 97.0%. Ultimately, employing all four imaging modalities resulted in AI achieving 98.0% sensitivity, 100% specificity, and 99.0% accuracy. In contrast, experts utilizing all four modalities attained a sensitivity of 78.0%, specificity of 82.0%, and accuracy of 81.0%. The AI models consistently outperformed the experts across all metrics. A continuous enhancement in performance was observed with each additional imaging modality, with AI utilizing three and four modalities significantly surpassing single-modal imaging AI. Conclusion AI utilizing multimodal imaging offers better performance compared to both single-modal imaging AI and experienced human experts in classifying SCN and MCN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.